Developing a physiologically based pharmacokinetic model of apixaban to predict scenarios of drug‐drug interactions, renal impairment and pediatric populations
2019 ◽
Vol 59
(6)
◽
pp. 781-808
◽
2017 ◽
Vol 45
(12)
◽
pp. 1304-1316
◽
2020 ◽
Vol 60
(8)
◽
pp. 999-1010
◽
2019 ◽
Vol 27
(3)
◽
pp. 107
◽